Literature DB >> 12491201

Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients.

Nina Singh1, Robin K Avery, Patricia Munoz, Timothy L Pruett, Barbara Alexander, Richard Jacobs, Jan G Tollemar, Edward A Dominguez, Chen M Yu, David L Paterson, Shahid Husain, Shimon Kusne, Peter Linden.   

Abstract

To discern whether the characteristics and outcome of invasive aspergillosis in liver transplant recipients have evolved during the past decade, 26 patients who underwent transplantation during 1990-1995 (known as "the earlier cohort") were compared with 20 patients who underwent transplantation during 1998-2001 (known as "the later cohort"). Twenty-three percent of the Aspergillus infections in the earlier cohort occurred > or =90 days after transplantation, compared with 55% of such infections in the later cohort (P=.026). The earlier cohort was significantly more likely to have disseminated infection (P=.034) and central nervous system (CNS) involvement (P=.0004) than was the later cohort. The mortality rate was significantly higher for the earlier cohort (92%) than for the later cohort (60%; P=.012). Only disseminated infection (not the year of transplantation) approached statistical significance as an independent predictor of outcome. In the current era, invasive aspergillosis occurs later in the posttransplantation period, is less likely to be associated with CNS infection, and is associated with a lower mortality rate, compared with invasive aspergillosis in the early 1990s.

Entities:  

Mesh:

Year:  2002        PMID: 12491201     DOI: 10.1086/345441

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  36 in total

1.  Efficacy of caspofungin as salvage therapy for invasive aspergillosis compared to standard therapy in a historical cohort.

Authors:  J W Hiemenz; I I Raad; J A Maertens; R Y Hachem; A J Saah; C A Sable; J A Chodakewitz; M E Severino; P Saddier; R S Berman; D M Ryan; M J Dinubile; T F Patterson; D W Denning; T J Walsh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-08-12       Impact factor: 3.267

2.  In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus isolates from transplant and nontransplant patients.

Authors:  William J Steinbach; Nina Singh; Jackie L Miller; Daniel K Benjamin; Wiley A Schell; Joseph Heitman; John R Perfect
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

Review 3.  Aspergillus infections in transplant recipients.

Authors:  Nina Singh; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

Review 4.  Cavitary pulmonary disease.

Authors:  L Beth Gadkowski; Jason E Stout
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

5.  Prophylaxis of invasive mycoses in solid organ transplantation.

Authors:  Kyle P Radack; Barbara D Alexander
Journal:  Curr Infect Dis Rep       Date:  2009-11       Impact factor: 3.725

Review 6.  The neurology of solid organ transplantation.

Authors:  J David Avila; Saša Živković
Journal:  Curr Neurol Neurosci Rep       Date:  2015-07       Impact factor: 5.081

Review 7.  Renal aspergillosis after liver transplantation: clinical and imaging manifestations in two cases.

Authors:  Xiao-Chun Meng; Ting Jiang; Shu-Hong Yi; Pei-Yi Xie; Yue-Fei Guo; Li Quan; Jing Zhou; Kang-Shun Zhu; Hong Shan
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

Review 8.  Invasive fungal infections in transplant recipients.

Authors:  Jose A Vazquez; Marisa H Miceli; George Alangaden
Journal:  Ther Adv Infect Dis       Date:  2013-06

9.  In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus.

Authors:  William J Steinbach; Wiley A Schell; Jill R Blankenship; Chiatogu Onyewu; Joseph Heitman; John R Perfect
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

10.  A risk profile for invasive aspergillosis in liver transplant recipients.

Authors:  M Rosenhagen; R Feldhues; J Schmidt; T Hoppe-Tichy; H K Geiss
Journal:  Infection       Date:  2009-07-23       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.